• A
  • A
  • A
日本語 Help
Science and technology information site for articles, patents, researchers information, etc.

Co-authoring Researcher

  • No item

Co-inventing Researcher

Researcher similar to the Researcher

Article similar to the Researcher

Patent similar to the Researcher

Research Project similar to the Researcher

Article(J-GLOBAL estimation)

Patent(J-GLOBAL estimation)

Rchr
J-GLOBAL ID:202101002766816190 Update date: Mar. 17, 2025

Kishimoto Mai

Kishimoto Mai
Clips

Papers (37)

  • Mai Kishimoto, Sakiho Imai, Manabu Igarashi, Masayuki Horie. Identification of an ambisense kolmiovirus from birds. 2025
  • Sakiho Imai, Mai Kishimoto, Masayuki Horie. Identification of a novel ephemerovirus in a water buffalo (Bubalus bubalis [Linnaeus, 1758]). Journal of Veterinary Medical Science. 2024. 86. 11. 1205-1211
  • Sakiho Imai, Mai Kishimoto, Masayuki Horie. Detection of a novel parahenipavirus from northern short-tailed shrews (Blarina brevicauda[Say, 1823]). 2024
  • Kittiya Intaruck, Koshiro Tabata, Yukari Itakura, Nijiho Kawaguchi, Mai Kishimoto, Agus Setiyono, Ekowati Handharyani, Hayato Harima, Takashi Kimura, William W Hall, et al. Characterization of a mammalian orthoreovirus isolated from the large flying fox, Pteropus vampyrus, in Indonesia. The Journal of general virology. 2024. 105. 9
  • Mai Kishimoto, Yukari Itakura, Koshiro Tabata, Rika Komagome, Hiroki Yamaguchi, Kohei Ogasawara, Ryo Nakao, Yongjin Qiu, Kozue Sato, Hiroki Kawabata, et al. A wide distribution of Beiji nairoviruses and related viruses in Ixodes ticks in Japan. Ticks and tick-borne diseases. 2024. 15. 6. 102380-102380
  • Michihito Sasaki, Tatsuki Sugi, Shun Iida, Yuichiro Hirata, Shinji Kusakabe, Kei Konishi, Yukari Itakura, Koshiro Tabata, Mai Kishimoto, Hiroko Kobayashi, et al. Combination therapy with oral antiviral and anti-inflammatory drugs improves the efficacy of delayed treatment in a COVID-19 hamster model. EBioMedicine. 2023. 99. 104950-104950
  • Koshiro Tabata, Yukari Itakura, Takuma Ariizumi, Manabu Igarashi, Hiroko Kobayashi, Kittiya Intaruck, Mai Kishimoto, Shintaro Kobayashi, William W Hall, Michihito Sasaki, et al. Development of flavivirus subviral particles with low cross-reactivity by mutations of a distinct antigenic domain. Applied microbiology and biotechnology. 2023
  • Tomokazu Tamura, Daichi Yamasoba, Yoshitaka Oda, Jumpei Ito, Tomoko Kamasaki, Naganori Nao, Rina Hashimoto, Yoichiro Fujioka, Rigel Suzuki, Lei Wang, et al. Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5. Communications Biology. 2023. 6. 1
  • Shigeru Fujita, Keiya Uriu, Lin Pan, Naganori Nao, Koshiro Tabata, Mai Kishimoto, Yukari Itakura, Hirofumi Sawa, Izumi Kida, Tomokazu Tamura, et al. Impact of imprinted immunity induced by mRNA vaccination in an experimental animal model. The Journal of infectious diseases. 2023
  • Yukari Itakura, Koshiro Tabata, Takeshi Saito, Kittiya Intaruck, Nijiho Kawaguchi, Mai Kishimoto, Shiho Torii, Shintaro Kobayashi, Naoto Ito, Michiko Harada, et al. Morphogenesis of Bullet-Shaped Rabies Virus Particles Regulated by TSG101. Journal of virology. 2023. 97. 5. e0043823
  • Mai Kishimoto, Masahiro Kajihara, Koshiro Tabata, Yukari Itakura, Shinsuke Toba, Seiya Ozono, Yuko Sato, Tadaki Suzuki, Naoto Ito, Katendi Changula, et al. Isolation and Characterization of Distinct Rotavirus A in Bat and Rodent Hosts. Journal of virology. 2023. 97. 1. e0145522
  • Hesham Nasser, Ryo Shimizu, Jumpei Ito, Akatsuki Saito, Kei Sato, Terumasa Ikeda, Keita Matsuno, Naganori Nao, Hirofumi Sawa, Mai Kishimoto, et al. Monitoring fusion kinetics of viral and target cell membranes in living cells using a SARS-CoV-2 spike-protein-mediated membrane fusion assay. STAR Protocols. 2022. 3. 4. 101773-101773
  • Michihito Sasaki, Koshiro Tabata, Mai Kishimoto, Yukari Itakura, Hiroko Kobayashi, Takuma Ariizumi, Kentaro Uemura, Shinsuke Toba, Shinji Kusakabe, Yuki Maruyama, et al. S-217622, a SARS-CoV-2 main protease inhibitor, decreases viral load and ameliorates COVID-19 severity in hamsters. Science translational medicine. 2022. 15. 679. eabq4064
  • Izumi Kimura, Daichi Yamasoba, Tomokazu Tamura, Naganori Nao, Tateki Suzuki, Yoshitaka Oda, Shuya Mitoma, Jumpei Ito, Hesham Nasser, Jiri Zahradnik, et al. Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants including BA.4 and BA.5. Cell. 2022. 185. 21. 3992-4007
  • Kittiya Intaruck, Yukari Itakura, Mai Kishimoto, Herman M Chambaro, Agus Setiyono, Ekowati Handharyani, Kentaro Uemura, Hayato Harima, Satoshi Taniguchi, Masayuki Saijo, et al. Isolation and characterization of an orthoreovirus from Indonesian fruit bats. Virology. 2022. 575. 10-19
  • Yutaro Neriya, Shohei Kojima, Arata Sakiyama, Mai Kishimoto, Takao Iketani, Tadashi Watanabe, Yuichi Abe, Hiroshi Shimoda, Keisuke Nakagawa, Takaaki Koma, et al. A comprehensive list of the Bunyavirales replication promoters reveals a unique promoter structure in Nairoviridae differing from other virus families. Scientific Reports. 2022. 12. 1. 13560
  • Koshiro Tabata, Yukari Itakura, Shinsuke Toba, Kentaro Uemura, Mai Kishimoto, Michihito Sasaki, Jessica J Harrison, Akihiko Sato, William W Hall, Roy A Hall, et al. Serological characterization of lineage II insect-specific flaviviruses compared with pathogenic mosquito-borne flaviviruses. Biochemical and biophysical research communications. 2022. 616. 115-121
  • Daichi Yamasoba, Izumi Kimura, Hesham Nasser, Yuhei Morioka, Naganori Nao, Jumpei Ito, Keiya Uriu, Masumi Tsuda, Jiri Zahradnik, Kotaro Shirakawa, et al. Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike. Cell. 2022. 185. 12. 2103-2115
  • Rigel Suzuki, Daichi Yamasoba, Izumi Kimura, Lei Wang, Mai Kishimoto, Jumpei Ito, Yuhei Morioka, Naganori Nao, Hesham Nasser, Keiya Uriu, et al. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Nature. 2022. 603. 7902. 700-705
  • Michihito Sasaki, Mai Kishimoto, Yukari Itakura, Koshiro Tabata, Kittiya Intaruck, Kentaro Uemura, Shinsuke Toba, Takao Sanaki, Akihiko Sato, William W Hall, et al. Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells. Biochemical and biophysical research communications. 2021. 577. 146-151

1 to 20 of 37 results
Return to Previous Page